GENNEX

GENNEX LABORATORIES

Small Cap BSE: 531739 NSE: GENNEX
₹6.59
-0.06 (-0.9%)
As on 13 August, 2022 | 05:08

Gennex Laboratories Share Price

Gennex Laboratories Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Gennex Laboratories Share Returns

  • Over 1 Month -1.35%
  • Over 3 Month 2.98%
  • Over 6 Month -27.96%
  • Over 1 Year -30.11%

Gennex Laboratories Key Statistics

Gennex Laboratories Investment Rating

  • Master Rating:
  • Gennex Laboratories has an operating revenue of Rs. 61.21 Cr. on a trailing 12-month basis. An annual revenue growth of 4% is not great, Pre-tax margin of 8% is okay, ROE of 8% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 200DMA and close to its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 56 which is a POOR score indicating inconsistency in earnings, a RS Rating of 26 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 105 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of E is the worst. Institutional holding has remained stable in the last reported quarter. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Gennex Laboratories Financials
  • Indicator
  • Mar 2022
  • Dec 2021
  • Sep 2021
  • Jun 2021
  • Mar 2021
  • Oper Rev Qtr Cr
  • 20
  • 17
  • 14
  • 10
  • 16
  • Operating Expenses Qtr Cr
  • 19
  • 15
  • 12
  • 9
  • 14
  • Operating Profit Qtr Cr
  • 1
  • 1
  • 2
  • 2
  • 3
  • Depreciation Qtr Cr
  • 0
  • 0
  • 0
  • 0
  • 0
  • Interest Qtr Cr
  • 0
  • 0
  • 0
  • 0
  • 0
  • Tax Qtr Cr
  • 0
  • 0
  • 0
  • 0
  • 0
  • Net Profit Qtr Cr
  • 1
  • 1
  • 1
  • 1
  • 2

Gennex Laboratories Technicals

EMA & SMA

Current Price
6.57
-0.08 (-1.2%)
  • Bullish Moving Average
  • ___
  • 1
  • Bearish Moving Average
  • ___
  • 15
  • 20 Day
  • 6.66
  • 50 Day
  • 6.83
  • 100 Day
  • 7.16
  • 200 Day
  • 7.87
  • 20 Day
  • 6.7
  • 50 Day
  • 6.8
  • 100 Day
  • 7.19
  • 200 Day
  • 7.88

Gennex Laboratories Resistance and Support

PIVOT
₹6.66
Resistance
  • First Resistance
  • 6.72
  • Second Resistance
  • 6.78
  • Third Resistance
  • 6.84
Support
  • First Resistance
  • 6.6
  • Second Resistance
  • 6.54
  • Third Resistance
  • 6.48
  • RSI
  • 45.36
  • MFI
  • 30.2
  • MACD Single Line
  • -0.07
  • MACD
  • -0.07

Gennex Laboratories Delivery and Volume

  • Period
  • NSE + BSE
    Volume Avg
  • NSE + BSE
    Delivery Volume Avg
  • NSE + BSE
    Delivery Volume %
  • Day
  • 226,329
  • 20,111,595
  • 88.86
  • Week
  • 301,213
  • 24,407,269
  • 81.03
  • 1 Month
  • 297,735
  • 21,809,124
  • 73.25
  • 6 Month
  • 283,394
  • 20,840,770
  • 73.54

Gennex Laboratories Result Highlights

Gennex Laboratories Synopsis

BSE-Medical-Diversified

Gennex Laboratories belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 59.65 Cr. and Equity Capital is Rs. 12.65 Cr. for the Year ended 31/03/2021. Gennex Laboratories Ltd. is a Public Limited Listed company incorporated on 29/03/1990 and has its registered office in the State of Andhra Pradesh, India. Company’s Corporate Identification Number(CIN) is L24230TG1990PLC011168 and registration number is 011168.
  • Market Cap
  • 94
  • Sales
  • 61
  • Shares in Float
  • 11.10
  • No of funds
  • 1
  • Yield
  • Book Value
  • 1.98
  • U/D Vol ratio
  • 1.3
  • LTDebt / Equity
  • Alpha
  • -0.1
  • Beta
  • 0.97

Gennex Laboratories

  • Owner Name
  • Jun-22
  • Mar-22
  • Dec-21
  • Sep-21
  • Promoters
  • 22.05%
  • 22.05%
  • 22.05%
  • Individual Investors
  • 74.5%
  • 75.16%
  • 73.7%
  • Others
  • 3.45%
  • 2.79%
  • 4.25%

Gennex Laboratories Management

  • Name
  • Designation
  • Mr. Arihant Baid
  • Chairman & Managing Director
  • Mr. T M Gopalakrishnan
  • Whole Time Director
  • Mr. A R R Pantulu
  • Non Executive Director
  • Mr. Y Ravinder Reddy
  • Independent Director
  • Mr. A S Nageswar Rao
  • Independent Director
  • Ms. Sadhana Bhansali
  • Independent Woman Director

Gennex Laboratories Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Gennex Laboratories Corporate Action

  • Date
  • Purpose
  • Remarks
  • 2022-08-12
  • Quarterly Results
  • 2022-07-16
  • Rights issue
  • 2022-06-24
  • Rights issue of Equity Shares
  • 2022-05-30
  • Audited & Quarterly Results
  • 2022-04-06
  • Rights issue

Gennex Laboratories FAQs

What is Share Price of Gennex Laboratories ?

Gennex Laboratories share price is ₹6 As on 13 August, 2022 | 04:54

What is the Market Cap of Gennex Laboratories ?

The Market Cap of Gennex Laboratories is ₹93.8 Cr As on 13 August, 2022 | 04:54

What is the P/E ratio of Gennex Laboratories ?

The P/E ratio of Gennex Laboratories is 21.3 As on 13 August, 2022 | 04:54

What is the PB ratio of Gennex Laboratories ?

The PB ratio of Gennex Laboratories is 1.9 As on 13 August, 2022 | 04:54

Q1FY23